Articles from Utah Medical Products, Inc.

SALT LAKE CITY, UT / ACCESS Newswire / September 15, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces today that it intends to repurchase at a price of $75.00 per share up to 650,000 of its shares, if tendered and not withdrawn by stockholders on or before October 7, representing approximately 20% of its currently outstanding shares. The offering price is 17% higher than the average daily closing price of UTMD shares trading in the open market during the last twelve months, and 21% higher than the average daily closing price of UTMD shares trading during the last two years. The highest intraday trading price during the last two years was $75.75.

SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of Utah Medical Products, Inc. (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.

SALT LAKE CITY, UT / ACCESS Newswire / August 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on October 5, 2026 to stockholders of record at the close of business on September 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.

SALT LAKE CITY, UT / ACCESS Newswire / July 23, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) reports second calendar quarter (2Q) and first half (1H) 2026 financial results with a continued decline in overall revenues in comparison to the same time periods in 2025.

SALT LAKE CITY, UT / ACCESSWIRE / May 10, 2022 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on July 6, 2022 to shareholders of record at the close of business on June 17, 2022. This is a 1.8% increase over the dividend declared in the same quarter of the prior year. Utah Medical Products, Inc., with particular

SALT LAKE CITY, UT / ACCESSWIRE / February 8, 2022 / Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine cents ($.29) per share of common stock payable on April 5, 2022 to shareholders of record at the close of business on March 18, 2022. This is a 1.8% increase over the dividend declared in the same quarter of the prior year. Utah Medical Products, Inc., with particular

SALT LAKE CITY, UT / ACCESSWIRE / November 2, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a special cash dividend of two dollars ($2.00) per share of common stock payable on December 29, 2021 to stockholders of record at the close of business on December 15, 2021. This dividend replaces the normal quarterly dividend, and will be paid in December rather than in early 2022. A key long term UTMD

SALT LAKE CITY, UT / ACCESSWIRE / August 3, 2021 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on October 5, 2021 to shareholders of record at the close of business on September 16, 2021. This is about a 2% increase over the dividend declared in the same quarter of the prior year. Utah Medical

SALT LAKE CITY, UT / ACCESSWIRE / May 11, 2021 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-eight and one-half cents ($.285) per share of common stock payable on July 6, 2021 to shareholders of record at the close of business on June 15, 2021. This is about a 2% increase over the dividend declared in the same quarter of the prior year. Utah Medical Products,